Search results
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2022, we invested $9.5 billion in R&D, which included the discovery and development of new medicines. Patients & caregivers. Our medicines.
- Get Help Paying for Medicines
If you have been prescribed a BMS medication, contact your...
- Worldwide Locations
Seattle, WA FUNCTION (S): R&D, GLOBAL PRODUCT DEVELOPMENT &...
- Eliquis
If you believe you have received the wrong dosage of Eliquis...
- Our R&D Team
Learn more about the backgrounds, scientific pursuits and...
- Get Help Paying for Medicines
Explore comprehensive information about Bristol Myers Squibb products including dosage and safety information. Learn more about our medicines today.
BMS Brands Advantage. Innovative. Our on trend product ranges allow our customers stay ahead of the curve. Quality Brands. Setting the standard for superior quality. Crafted with precision, delivered with care. Trusted Service. Experience reliability in every interaction.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Feb 5, 2020 · Bristol-Myers Squibb’s (NYSE: BMY) top 3 selling drugs (excluding that of Celgene) are Eliquis, Opdivo, and Orencia. These three drugs combined, likely accounted for three-fourths of the...
Feb 2, 2024 · Besides Opdivo, Breyanzi and Abecma, BMS’ growth portfolio also features immuno-oncology therapies Opdualag and Yervoy, plus the newly bought KRAS inhibitor Krazati, and the newly FDA-approved ...
